Update in Otology and Otolaryngology – A Virtual Experience - 2021

Friday, November 5, 2021, 8:00 AM - 5:30 PM

Online preregistration is closed. For questions contact the Virginia Mason CME department at (206) 341-0142.

The Virginia Mason Franciscan Health Update in Otology and Otolaryngology – A Virtual Experience provides a unique opportunity for otolaryngologists, advanced practitioners, and otolaryngology trainees to increase their knowledge and competence in the work-up and surgical care of otologic diseases, as well as to explore a variety of other topics within the field. Due to continuing precautions on in-person gatherings, this full day course will be presented online via livestream.

The morning begins with live on-line observation of otologic surgery performed by a Virginia Mason Franciscan Health otologist. Two procedures will be completed and during these procedures, you will hear from the surgeon and have the ability to interact with the MD facilitator who will address your questions in real time.

The afternoon online lectures will feature both local and national experts in their fields. The afternoon begins with information on the management of thyroid cancer according to the most recent guideline recommendations, followed by a review on the treatment of pediatric obstructive sleep apnea, approaches to anterior skull base reconstruction, and a review of the diagnosis and management of cholesteatoma. This afternoon will include a review on functional rhinoplasty, treatment options for conductive hearing loss, management of vestibular migraine from a neurologist’s viewpoint, and will close with a discussion about upper esophageal sphincter dysfunction with a laryngologist.

Teaching methods include surgical observation, lectures, and questions and answers with faculty.

1. Explain the rising incidence of thyroid cancer in the US
2. Discuss a practical approach to the use of drug-induced sleep endoscopy in children
3. Review the pathophysiology of nasal obstruction and how to identify common causes in the history and physical exam
4. Describe the variations in skull base defects and factors related to reconstruction choices including size, location, and intracranial pressure
5. Formulate a workable differential diagnosis for causes of conductive hearing loss
6. Identify the spectrum of migraine associated vertigo or vestibular migraines
7. Discuss the pathogenesis of cholesteatoma
8. Identify appropriate application of surgical and non-surgical approaches to Upper Esophageal Sphincter (UES) dysfunction

Tuition: $85.00
Online registration will be open through Thursday, November, 3rd. For registration assistance, call the CME department at 206.341.0142.

The Virginia Mason Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Virginia Mason Medical Center designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABOHNS RECOGNITION STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

AMA PRA Category 1 Credit(s)™ (4.00 hours), ABOHNS MOC Part II (4.00 hours), Non-Physician Attendance (4.00 hours)

Mitigation of Relevant Financial Relationships

Virginia Mason Medical Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, November 5, 2021